Evidence map›Paper›PMID 42796663›Full record

ArticlePathogens (Basel, Switzerland)2026

A Paired-Marker Framework for Interpreting Anti-

Aidar Namet, Mukhit Orynbayev, Timur Davlyatshin, Kulyaisan Sultankulova, Asylzhan Myrzakhmet, Sabyrkhan Barmak, Dulat Inkarbekov, Oralkhan Tusipkanuly, Aiganym Tussipova, Berik Khairullin

Abstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Aidar NametScientific Research and Production Center «MVA GROUP» LLP, 1124, Accounting Quarter 096, Koksay Village, Irgeli Rural District, Karasay District, Almaty Region, Almaty 040921, Kazakhstan.
Mukhit OrynbayevScientific Research and Production Center «MVA GROUP» LLP, 1124, Accounting Quarter 096, Koksay Village, Irgeli Rural District, Karasay District, Almaty Region, Almaty 040921, Kazakhstan.ORCID 0000-0002-5882-4964
Timur DavlyatshinScientific Research and Production Center «MVA GROUP» LLP, 1124, Accounting Quarter 096, Koksay Village, Irgeli Rural District, Karasay District, Almaty Region, Almaty 040921, Kazakhstan.ORCID 0000-0002-1064-7081
Kulyaisan SultankulovaScientific Research and Production Center «MVA GROUP» LLP, 1124, Accounting Quarter 096, Koksay Village, Irgeli Rural District, Karasay District, Almaty Region, Almaty 040921, Kazakhstan.
Asylzhan MyrzakhmetScientific Research and Production Center «MVA GROUP» LLP, 1124, Accounting Quarter 096, Koksay Village, Irgeli Rural District, Karasay District, Almaty Region, Almaty 040921, Kazakhstan.ORCID 0000-0003-4107-5095
Sabyrkhan BarmakScientific Research and Production Center «MVA GROUP» LLP, 1124, Accounting Quarter 096, Koksay Village, Irgeli Rural District, Karasay District, Almaty Region, Almaty 040921, Kazakhstan.
Dulat InkarbekovScientific Research and Production Center «MVA GROUP» LLP, 1124, Accounting Quarter 096, Koksay Village, Irgeli Rural District, Karasay District, Almaty Region, Almaty 040921, Kazakhstan.
Oralkhan TusipkanulyScientific Research and Production Center «MVA GROUP» LLP, 1124, Accounting Quarter 096, Koksay Village, Irgeli Rural District, Karasay District, Almaty Region, Almaty 040921, Kazakhstan.
Aiganym TussipovaScientific Research and Production Center «MVA GROUP» LLP, 1124, Accounting Quarter 096, Koksay Village, Irgeli Rural District, Karasay District, Almaty Region, Almaty 040921, Kazakhstan.ORCID 0000-0002-7767-0542
Berik KhairullinScientific Research and Production Center «MVA GROUP» LLP, 1124, Accounting Quarter 096, Koksay Village, Irgeli Rural District, Karasay District, Almaty Region, Almaty 040921, Kazakhstan.

Funding

Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan IRN BR28712927 «Scientific and technological support for biological safety of the Republic of Kazakhstan in the field of medical parasitology» for 2025-2027.
6 · The paper itself

Abstract

backgroundStool microscopy and anti-

objectiveTo develop a four-pattern paired-marker framework for anti-

methodsThe cross-sectional field study involved 1000 adult volunteers from Almaty and the region providing matched serum and stool samples. Sera were tested by MVA Group indirect anti-

resultsAnti-

conclusionsSerology and copromicroscopy showed a high association, but they are not interchangeable. The paired-marker paradigm clarified concordant and discordant patterns while retaining IgG as a marker of past or ongoing immune exposure and stool eggs as markers of shedding at the time of sampling. High inter-assay agreement suggests analytical consistency within this serum panel, but does not imply diagnostic accuracy for active ascariasis.

Indexed as

Antibodies, HelminthAscariasisAscaris lumbricoidesFecesImmunoglobulin GAdolescentAdultAnimalsBiomarkersCross-Sectional StudiesEnzyme-Linked Immunosorbent AssayFemaleHumansKazakhstanMaleMicroscopyAntibodies, HelminthBiomarkersImmunoglobulin Ganalytical agreementascariasisAscaris lumbricoidescopromicroscopyenzyme-linked immunosorbent assayimmunological exposureKazakhstanseroepidemiology

Identifiers

PMID42796663
PMCPMC13610317

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.